Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Ferroportin disease (hemochromatosis type 4) is a recently recognized disorder of human iron metabolism, characterized by iron deposition in macrophages, including Kupffer cells. Mutations in the gene encoding ferroportin 1, a cellular iron exporter, are responsible for this iron storage disease, inherited as an autosomal dominant trait. We present clinical, histopathological, and radiological findings in a family with the most common ferroportin mutation, V162del. In the index case, the disorder is characterized by abundant deposition of hemosiderin in all tissues investigated (mesenteric lymph node, liver, gastric and duodenal mucosa, and also in squamous cell carcinoma of the lung). The radiological findings indicated the presence of excess iron in bone marrow and spleen. Despite a significant burden of iron, no features of chronic liver disease were found in affected members of the family, including individuals aged up to 80 years. Hyperferritinemia greater than 1,000 microg/L was a penetrant biochemical finding before the second decade in life and was associated with significantly increased serum concentrations of pro-hepcidin that correlated positively with urinary hepcidin concentrations. In conclusion, the systemic iron burden in ferroportin disease is not a sufficient cause for chronic liver disease. In patients with most, but not all, ferroportin mutations, retention of iron in macrophages of the liver and other organs may protect against damage to parenchymal cells. Finally, macrophage iron storage in ferroportin disease is associated with elevated serum pro-hepcidin levels.
Clinical Division of Gastroenterology and Hepatology, Innsbruck Medical University, Innsbruck, Austria. heinz.zoller@uibk.ac.at
Heinz
H
Zoller
Ian
I
McFarlane
Igor
I
Theurl
Sylvia
S
Stadlmann
Elizabeta
E
Nemeth
David
D
Oxley
Tomas
T
Ganz
David J
DJ
Halsall
Timothy M
TM
Cox
Wolfgang
W
Vogel
D000293:Adolescent; D000328:Adult; D000368:Aged; D023181:Antimicrobial Cationic Peptides / Q000097:blood*; D027682:Cation Transport Proteins / Q000235:genetics*; D005293:Ferritins / Q000097:blood; D006432:Hemochromatosis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D064451:Hepcidins; D006801:Humans; D019190:Iron Overload / Q000235:genetics / Q000378:metabolism*; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011498:Protein Precursors / Q000097:blood*; D000098742:Ferroportin
D023181:Antimicrobial Cationic Peptides; D027682:Cation Transport Proteins; C578702:HAMP protein, human; D064451:Hepcidins; D011498:Protein Precursors; D000098742:Ferroportin; D005293:Ferritins